These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21913962)

  • 1. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review.
    Hellemons ME; Kerschbaum J; Bakker SJ; Neuwirt H; Mayer B; Mayer G; de Zeeuw D; Lambers Heerspink HJ; Rudnicki M
    Diabet Med; 2012 May; 29(5):567-77. PubMed ID: 21913962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.
    Persson F; Rossing P; Hovind P; Stehouwer CD; Schalkwijk CG; Tarnow L; Parving HH
    Scand J Clin Lab Invest; 2008; 68(8):731-8. PubMed ID: 18609080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary biomarkers reporting weakness and validation failure in Type 2 diabetic nephropathy: systematic review.
    Siddiqui K; Joy SS; Ilias S; Alzeer HS; Al-Rubeaan K
    Biomark Med; 2018 May; 12(5):487-499. PubMed ID: 29697277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus.
    Polat SB; Ugurlu N; Aslan N; Cuhaci N; Ersoy R; Cakir B
    Arch Endocrinol Metab; 2016 Apr; 60(2):117-24. PubMed ID: 26886090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.
    Stehouwer CD; Gall MA; Twisk JW; Knudsen E; Emeis JJ; Parving HH
    Diabetes; 2002 Apr; 51(4):1157-65. PubMed ID: 11916939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study.
    Moh AMC; Pek SLT; Liu J; Wang J; Subramaniam T; Ang K; Sum CF; Kwan PY; Lee SBM; Tang WE; Lim SC
    Diabetes Res Clin Pract; 2020 Mar; 161():107992. PubMed ID: 32032675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Hanai K; Babazono T; Nyumura I; Toya K; Tanaka N; Tanaka M; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2009 Jun; 24(6):1884-8. PubMed ID: 19131352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers?
    Wu T; McGrath KC; Death AK
    Vasc Health Risk Manag; 2005; 1(4):309-16. PubMed ID: 17315603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.
    Lin J; Glynn RJ; Rifai N; Manson JE; Ridker PM; Nathan DM; Schaumberg DA
    Diabetes Care; 2008 Dec; 31(12):2338-43. PubMed ID: 18796620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.
    Shikano M; Sobajima H; Yoshikawa H; Toba T; Kushimoto H; Katsumata H; Tomita M; Kawashima S
    Nephron; 2000 May; 85(1):81-5. PubMed ID: 10773760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes.
    Bekpinar S; Yenidunya G; Gurdol F; Unlucerci Y; Aycan-Ustyol E; Dinccag N
    Clin Biochem; 2015 Dec; 48(18):1264-7. PubMed ID: 26255120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.
    Lenghel AR; Kacso IM; Bondor CI; Rusu C; Rahaian R; Gherman Caprioara M
    Diabetes Res Clin Pract; 2012 Jan; 95(1):55-61. PubMed ID: 21945031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria.
    Karimi Z; Kahe F; Jamil A; Marszalek J; Ghanbari A; Afarideh M; Khajeh E; Noshad S; Esteghamati A; Chi G
    Diabetes Metab Syndr; 2018 May; 12(3):365-368. PubMed ID: 29310968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and validation of serum creatinine variability as novel biomarker for predicting onset of albuminuria in Type 2 diabetes mellitus.
    Low S; Zhang X; Ang K; Yeo SJD; Lim GJ; Yeoh LY; Liu YL; Subramaniam T; Sum CF; Lim SC
    Diabetes Res Clin Pract; 2018 Apr; 138():8-15. PubMed ID: 29355653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST; Tseng ST
    Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
    Kishore L; Kaur N; Singh R
    Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.